Blood Transfusion Recipients with Alloantibodies of Anti C, c, E, e and Anti D+C (?G): A Series of 11 Cases

The process whereby non ABO antibodies form after a Red Blood Cell (RBC) transfusion, pregnancy, or transplantation is known as alloimmunisation. The likelihood of developing alloimmunisation is influenced by factors such as transfusions, multiple pregnancies, underlying diseases, the cause of anaem...

Full description

Saved in:
Bibliographic Details
Main Authors: Athulya A Bhagya, A Ashwin, R Krishnamoorthy, R Niranj Rathan, M Sampat Kumar
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-08-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&volume=19&issue=8&page=ER01&issn=0973-709x&id=21410
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The process whereby non ABO antibodies form after a Red Blood Cell (RBC) transfusion, pregnancy, or transplantation is known as alloimmunisation. The likelihood of developing alloimmunisation is influenced by factors such as transfusions, multiple pregnancies, underlying diseases, the cause of anaemia, and the recipient’s immune response to the non-self RBC antigens they encounter. Alloantibodies can complicate crossmatch testing, leading to delays in securing compatible blood. Therefore, for a patient with a history of detectable clinically significant antibodies, donor units selected for transfusion must be negative for the corresponding antigen(s). In this context, the authors present a series of 11 cases (7males ,4 females) transfusion recipients and their characteristics for being at risk of alloimmunisation.
ISSN:2249-782X
0973-709X